Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Alopecia areata might help slow down certain cancers.

Secukinumab can cause hair loss, which may improve after stopping the medication.

The skin microbiome helps heal wounds and can be targeted to improve healing.

Most pregnant women experience common skin changes like linea nigra and stretch marks.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Retinoids and narrowband UVB phototherapy are effective for treating psoriasis and can reduce treatment time when used together.

These gene variations are not linked to alopecia areata in Egyptians.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

Graphene oxide helps deliver a skin healing agent over time, improving skin and hair follicle regeneration.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Increasing sebum production might help reduce fat and improve metabolism.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.